Introduction: Anti-phospholipase A2 receptor antibody (PLA2R-Ab) is highly specific for
primary membranous nephropathy (PMN). Here, we compare the diagnostic value of …

Lessons from an animal model that faithfully resembles human membranous nephropathy
(MN) have informed our understanding of the pathogenesis of this organ-specific …

The diagnostic performance of M-type phospholipase A2 receptor (PLA2R) autoantibodies
and PLA2R glomerular staining in discriminating between idiopathic membranous …

Background The binding of anti-phospholipase A2 receptor (anti-PLA2R) antibody to
podocyte and complement activation is the mechanisms of idiopathic membranous …

Background. The role of IgG subclass in idiopathic membranous nephropathy (IMN) was
unclarified. Recent study found IgG subtype switches from IgG1 to IgG4 in the early …

Introduction The prognostic value of PLA2R antibody (Ab) test in clinical practice remains
unclear. We aimed to evaluate its ability in predicting hard outcomes in primary …

Introduction: B-cell depletion has been shown to be an effective strategy for the majority of
patients with membranous nephropathy (MN), and in PLA2R-positive MN, immunologic …

M-type phospholipase A2 receptor (PLA2R) is the major target antigen in primary
membranous nephropathy (PMN). Previous studies have evaluated the diagnostic value of …

Methods: We performed a retrospective analysis of 519 biopsy-proven PLA2R-associated
primary membranous nephropathy patients with baseline eGFR≥ 25ml/min/1.73 m 2. The …

The M-type phospholipase A2 receptor autoreactive antibodies (PLA2R-Ab) represent the
leading cause of primary membranous nephropathy (pMN)[1]. Several studies report …